Avidity Biosciences Inc (RNA)

12:40 PM

Avidity Biosciences shares climb after FDA grants Breakthrough Therapy designation - MSN

12:40 PM

06:14 AM

What drives Avidity Biosciences Inc. stock priceOverwhelming profit margins - jammulinksnews.com

06:14 AM

Jul 23, 2025

Avidity Biosciences Gains FDA Breakthrough Therapy Designation - TipRanks

Jul 23, 2025

Jul 23, 2025

Why Avidity Biosciences Inc. stock attracts strong analyst attentionFree Stock Movement Tracking - beatles.ru

Jul 23, 2025

Jul 23, 2025

Avidity gets FDA breakthrough therapy status for DMD treatment - Seeking Alpha

Jul 23, 2025

Jul 23, 2025

FDA grants breakthrough therapy status to Avidity’s DMD drug By Investing.com - Investing.com Canada

Jul 23, 2025

Jul 23, 2025

Avidity Biosciences stock rises after FDA grants Breakthrough Therapy status - Investing.com

Jul 23, 2025

Jul 23, 2025

Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping - PR Newswire

Jul 23, 2025

Jul 23, 2025

What analysts say about Avidity Biosciences Inc. stockOutstanding capital appreciation - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Is Avidity Biosciences Inc. a good long term investmentTriple-digit returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Avidity Biosciences Inc. Stock Analysis and ForecastExtraordinary market timing - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

(RNA) On The My Stocks Page - news.stocktradersdaily.com

Jul 18, 2025

Jul 14, 2025

Avidity Biosciences: Three Accelerated Approval Shots Feels Excessive (NASDAQ:RNA) - Seeking Alpha

Jul 14, 2025

Jul 14, 2025

RNA News Today | Why did Avidity Biosciences stock drop today? - MarketBeat

Jul 14, 2025

Jul 10, 2025

Goldman Sachs resumes coverage on Avidity Biosciences stock with Buy rating - Investing.com Canada

Jul 10, 2025

Jul 09, 2025

Avidity Biosciences, Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Jul 09, 2025

Jul 09, 2025

Avidity Biosciences, Inc Rings the Opening Bell - Nasdaq

Jul 09, 2025

Jul 07, 2025

Avidity Biosciences’ SWOT analysis: innovative muscle therapy stock faces key milestones - Investing.com

Jul 07, 2025

Jun 30, 2025

Avidity Biosciences, Inc.(NasdaqGM: RNA) added to Russell 3000E Value Index - MarketScreener

Jun 30, 2025

Jun 27, 2025

(RNA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 27, 2025

Jun 26, 2025

Avidity Biosciences’ Promising Phase 3 Study on FSHD Treatment: Market Implications - TipRanks

Jun 26, 2025

Jun 18, 2025

Avidity Biosciences’ SWOT analysis: innovative RNA firm eyes 3-drug launch by 2027 - Investing.com

Jun 18, 2025

Jun 17, 2025

Wolfe Research Initiates Coverage on Avidity Biosciences (RNA) with 'Outperform' Rating | RNA Stock News - GuruFocus

Jun 17, 2025

Jun 17, 2025

Avidity Biosciences (RNA) Receives Outperform Rating Amid Biotec - GuruFocus

Jun 17, 2025

Jun 17, 2025

Why Avidity Biosciences Shares Are Under the Spotlight - TipRanks

Jun 17, 2025

Jun 17, 2025

Wolfe Research Initiates Coverage on Avidity Biosciences With Outperform Rating, $55 Price Target - MarketScreener

Jun 17, 2025

Jun 17, 2025

Avidity Biosciences (RNA) Receives Outperform Rating Amid Biotech Advancements | RNA Stock News - GuruFocus

Jun 17, 2025

Jun 16, 2025

(RNA) Proactive Strategies - news.stocktradersdaily.com

Jun 16, 2025

Jun 16, 2025

Avidity Biosciences (RNA) Receives Outperform Rating from Wolfe Research | RNA Stock News - GuruFocus

Jun 16, 2025

Jun 15, 2025

The week in pharma: action, reaction and insight – week to June 13 - The Pharma Letter

Jun 15, 2025

Jun 14, 2025

Avidity Biosciences’ SWOT analysis: innovative RNA tech targets rare disease stock potential - Investing.com Australia

Jun 14, 2025

Jun 14, 2025

Avidity Biosciences’ SWOT analysis: innovative RNA tech targets rare disease stock potential By Investing.com - Investing.com South Africa

Jun 14, 2025

Jun 13, 2025

Avidity Biosciences chief scientific officer sells $657,694 in stock - Investing.com India

Jun 13, 2025

Jun 13, 2025

Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James - MSN

Jun 13, 2025

Jun 12, 2025

Avidity Biosciences chief scientific officer sells $657,694 in stock By Investing.com - Investing.com South Africa

Jun 12, 2025